Health Care Professionals
The Oncofertility Consortium seeks out ways to encourage collaboration between oncologists and reproductive endocrinologists and develop opportunities for training new oncofertility scholars who can bridge the gap between these disciplines and effectively communicate fertility-preservation options to patients at the time of their diagnosis, before treatment begins.
In this section, you can find out more about the National Physicians Cooperative (NPC), a national network of institutions dedicated to facilitating the translation of basic reproductive physiology research to viable fertility-preservation options for patients diagnosed with cancer and other serious diseases.
How Can I Get Involved? The Oncofertility Consortium® is committed to interdisciplinary innovation. We realize the great value in convening experts from a wide range of disciplines and from diverse geographical locations. By fostering collaboration across our vast network of researchers, we hope to create a dynamic and interactive exchange of ideas. Please visit the links that follow to learn how you can become involved with this exciting and ever-evolving organization. |
The National Physicians Cooperative (NPC) Membership Info and NPC Resources The National Physicians Cooperative (NPC)is a nationwide network of comprehensive fertility preservation centers. The network was established to provide a collaborative forum for the exchange of ideas, clinical research methods, and technologies in order to drive breakthroughs in basic reproductive physiology that will be translated directly to clinical medicine. The NPC is currently comprised of 4 core institutions and over 50 Allied health care centers across the country. The NPC is led by Mary Ellen Pavone, MD, MSCI, and Jacqueline Jeruss, MD, PhD, at Northwestern University. We provide a wide range of resources on how to make a referral for fertility preservation, how to navigate financial/billing issues, and new developments that may affect your patients. |
Launch a fertility preservation program
Patients with a disease whose treatment or progression can impair fertility often require access to fertility preservation interventions before treatment begins. While cancer is the most urgent of these conditions, patients with rheumatologic diseases (like lupus, rheumatoid arthritis, ulcerative colitis), neurologic diseases like MS, and hematologic diseases that may require a bone marrow transplant (such as sickle cell and thalassemia) may also benefit from a fertility preservation consultation. Implementation of a Fertility Preservation Program
|
Media for Health Care Professionals Learn about the progress the Oncofertility Consortium® has made by viewing archived videos of Virtual Grand Rounds, the annual Oncofertility Consortium® Conference, trainings, presentations, and webinars. |
Did you know that cancer treatments can affect the fertility of men, women, and children? Fertility preservation methods are most effective when used before cancer treatments begin.
For information about fertility preservation or to get a referral to a fertilty preservation center near you, please call the FERTLINE! This resource is available to patients, families and health care professionals.






